Pip6a-PMO

N/A

Report date: 2025/04/21 17:03:46

NME

Base Information

Drug NamePip6a-PMO

Drug Alias NamePip6a-PMO

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Peptide-oligonucleotide ConjugateSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) > Peptide-oligonucleotide Conjugate

Mechanisms of ActionSMN gene transference

TargetsSurvival motor neuron protein

Therapy Area/IndicationsMuscular Atrophy, Spinal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Oxford

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oxford

Inactive CompaniesN/A

Active IndicationsMuscular Atrophy, Spinal

Inactive IndicationsN/A

Other Information

ATC CodeN/A